Importance of the pre-analytical phase in blood glucose analysis

Acta Clinica Belgica

Volumn 65, Issue 5, 2010, Pages 311-318

  Janssen, K ^a   Delanghe, Joris ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood glucose analysis; Point of care testing; Pre analytical

Indexed keywords

ASCORBIC ACID; DOPAMINE; GLUCOSE; MANNITOL; OXYGEN; PARACETAMOL;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CRITICALLY ILL PATIENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEALTH CARE PERSONNEL; HEMOLYSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE; LABORATORY TEST;

EID: 78149366177     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2010.068     Document Type: Article

References (53)

1. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 2005; 51: 1573-6. (Pubitemid 41233089)
2. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436-72.
3. Young DS. Conveying the importance of the preanalytical phase. Clin Chem Lab Med 2003; 41: 884-7.
4. Kalra J. Medical errors: impact on clinical laboratories and other critical areas. Clin Biochem 2004; 37: 1052-62. (Pubitemid 39601092)
5. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44: 358-65.
6. Berth M, Bafort K, Bosmans E, et al. Foutieve resultaten van veneuze bloedafname in het klinisch laboratorium. Tijdschrift voor Geneeskunde 2007; 63: 797-803.
7. Narayanan S. The preanalytical phase: an important component of laboratory medicine. Am J Clin Pathol 2000; 113: 429-52.
8. Stahl M, Jørgensen LGM, Hyltoft Petersen P, Brandslund I, De Fine Olivarius N, K. Borch-Johnsen. Optimization of preanalytical conditions and analysis of plasma glucose. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scan J Clin Lab Invest 2001; 61: 169-80.
9. rd revised edition. Darmstadt, Germany: Wiley-VCH Verlag GmbH. 2003: 34-5.
10. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 2001; 307: 187-92.
11. Colagiuri S, Sandbæk A, Carstensen B, et al. Comparability of venous and capillary glucose measurements in blood. Diabet Med 2003; 20: 953-6.
12. Neely RDG, Kiwanuka JB, Hadden DR. Influence of sample type on the interpretation of the oral glucose tolerance test for gestational diabetes mellitus. Diabet Med 1991; 8: 129-34.
13. Farrer M, Fulcher G, Albers CJ, Neil HA, Adams PC, Alberti KG. Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year. Metabolism 1995; 44: 1016-27.
14. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
15. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation. 2006; 1-46.
16. Larsson-Cohn U. Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand J Clin Lab Invest 1976; 36: 805-8.
17. Lind T, De Groot HA, Brown G, Cheyne GA. Observations on blood glucose and insulin determinations. BMJ 1972; 3: 320-3.
18. Khan AI, Vasquez Y, Gray J, Wians FH, Kroll MH.The variability of results between Point-Of-Care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 2006; 130: 1527-32. (Pubitemid 44520721)
19. Stahl M, Brandslund I, Jørgensen LGM, Hyltoft Petersen P, Borch-Johnsen K, De Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest 2002; 62: 159-66.
20. rd revised edition. Darmstadt, Germany: Wiley-VCH Verlag GmbH. 2003: 19.
21. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of short-term venous stasis on clinical chemistry testing. Clin Chem Lab Med 2005; 43: 869-75.
22. Burrin JM, Alberti KGMM. What is blood glucose: can it be measured? Diabet Med 1990; 7: 199-206.
23. D'Orazio P, Burnett RW, Fogh-Andersen N et al. Approved IFCC recommendation on reporting results for blood glucose. Clin Chem Lab Med 2006; 44: 1486-90. (Pubitemid 44967700)
24. Floré KM, Fiers T, Delanghe JR. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med 2008; 46: 1763-8.
25. le Roux CW, Wilkinson SD, Pavitt DV, Muller BR, Alaghband-Zadeh J. A new antiglycolytic agent. Ann Clin Biochem 2004; 41: 43-6.
26. rd ed. Philadelphia: WB Saunders. 1999: 750-808.
27. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization Department of Non-communicable Disease Surveillance, 1999; 1-59.
28. Chan AYW, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989; 35: 315-7.
29. Ladenson JH. Nonanalytical sources of variation clinical chemistry results. In: Sonnenwirth A, Jarett L, eds. Clinical laboratory methods and diagnosis. St. Louis, MO: CV Mosby. 1980: 149-92.
30. Meites S, Saniel-Banrey K. Preservation, distribution and assay of glucose in blood, with special reference to the newborn. Clin Chem 1979; 25: 531-4.
31. Gambino R, Piscitelli J, Ackattupathil TA, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009; 55: 1019-21
32. Chan AYW, Cockram CS, Swaminthan R. Effect of delay in separating plasma for glucose measurement upon the interpretation of oral glucose tolerance tests. Ann Clin Biochem 1990; 24: 73-4.
33. rd revised edition. Darmstadt, Germany: Wiley-VCH Verlag GmbH. 2003: 80-1.
34. Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodxtrin metabolites in some enzymatic glucose methods. Clin Chem 1998; 44: 2379-80.
35. Apperloo JJ, Vader HL. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses. Clin Chem Lab Med 2005;43:314-8.
36. Kost GJ, Vu HT, Lee JH, et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 1998; 26: 581-90.
37. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol 2000; 113: 75-86. (Pubitemid 30217342)
38. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem 1994; 40: 1628-30.
39. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparison of testing quality achieved by patients and a technician. Clin Chem 2002; 48: 994-1003. (Pubitemid 34680893)
40. Plessis du M, Ubbink JB, Vermaak WJH. Analytical quality of near-patient blood cholesterol and glucose measurement. Clin Chem 2000; 46: 1085-90.
41. American Diabetes Association. Consensus statement: self-monitoring of blood glucose. Diabetes Care 1990; 13(Suppl 1): 41-6.
42. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 1994; 17: 81-6.
43. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 1996; 19(Suppl 1): S62-6.
44. National Committee for Clinical Laboratory Standards. Ancillary (bedside) blood glucose testing in acute and chronic care facilities; approved guideline C30-A. Villanova, PA: NCCLS, 1994; 14: 1-14.
45. CLSI. Point-of-care blood glucose testing in acute and chronic care facilities; Approved guideline. Second edition. 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2002. CLSI document C30-A2.
46. Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59: 491-500. (Pubitemid 30056739)
47. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000; 124: 1135-40.
48. Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.
49. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care 2006; 10: R19.
50. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39.
51. Inzucchi SE, Siegel MD. Glucose control in the ICU - How tight is too tight? N Engl J Med 2009; 360: 1346-9.
52. Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marnik P. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med 2007; 33: 2079-84. (Pubitemid 350164561)
53. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 2001; 47: 209-14.